PhD Statistics Intern at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Currently enrolled in a PhD Program in Statistics or Biostatistics
Passed qualification exam
Will complete the third year by May 2026
Proficient in statistical programming languages/software such as SAS, R, Python, etc
Interpersonal communication skills for effective customer consultation
Technical expertise and application with working knowledge of experimental design and statistical analysis
Creativity and innovation
Demonstrated problem solving ability and strategic thinking

Responsibilities

Partner with experts in statistics, basic science and medical to optimize drug discovery and development processes
Introduce and apply innovative methodology and tools to solve critical problems
Be accurate and creative in communicating results
Be up to date on novel and state of the art data and analytics technologies and approaches
Challenge yourself and others to be a life-long learner and always look for better ways to deliver

Skills

Statistics

Biostatistics

Bayesian statistics

Machine Learning

Causal Inference

Adaptive Designs

Genetic Analysis

Biomarker Analysis

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free